The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Simultaneous molecular alterations in solid tumors with IDH1 or IDH2 mutations.
 
Filip Janku
Consulting or Advisory Role - Deciphera; Foundation Medicine; Guardant Health; Novartis; Sequenom; Trovagene
Research Funding - Agios; Astellas Pharma; Biocartis; BioMed Valley Discoveries; Deciphera; Foundation Medicine; Fujifilm; Novartis; Piqur; Plexxikon; Roche; Symphony Evolution; Trovagene
Other Relationship - Bio-Rad
 
John Frederick De Groot
Employment - Helsinn Therapeutics (I)
Leadership - ZIOPHARM Oncology (I)
Stock and Other Ownership Interests - Gilead Sciences
Consulting or Advisory Role - Celldex; Deciphera; Foundation Medicine; Genentech/Roche; Vascular Biogenics
Speakers' Bureau - Celldex; Deciphera; Omniox; Oxigene
Research Funding - Deciphera; EMD Serono; Lilly; Novartis; Sanofi
Patents, Royalties, Other Intellectual Property - AstraZeneca - Research Support; Deciphera Pharmaceuticals - Research Support; Eli Lilly - Research Support; EMD-Serono - Research Support; Novartis - Research Support; Sanofi-Aventis - Research Support
 
Milind M. Javle
No Relationships to Disclose
 
Marta Penas-Prado
Research Funding - Abbvie (Inst); Agios (Inst); DelMar Pharmaceuticals (Inst); DNAtrix (Inst); Genentech/Roche (Inst); Novartis (Inst); Orbus Therapeutics (Inst)
 
Rachna T. Shroff
Stock and Other Ownership Interests - Celgene
Consulting or Advisory Role - Agios; Amgen; Celgene; Clovis Oncology; Codiak Biosciences
Research Funding - Agios; Celgene; Lilly
Travel, Accommodations, Expenses - Amgen; Celgene; Codiak Biosciences
 
Rajyalakshmi Luthra
No Relationships to Disclose
 
Kimberly Banks
Employment - Guardant Health
Stock and Other Ownership Interests - Guardant Health
Patents, Royalties, Other Intellectual Property - Guardant Health
 
Richard B. Lanman
Employment - Guardant Health; Veracyte
Leadership - Guardant Health
Stock and Other Ownership Interests - Guardant Health; Veracyte
Research Funding - Guardant Health
 
Anthony Paul Conley
No Relationships to Disclose
 
Russell Broaddus
No Relationships to Disclose
 
Michael A. Davies
Consulting or Advisory Role - Genentech/Roche; GlaxoSmithKline; Novartis; Sanofi; Vaccinex
Research Funding - AstraZeneca (Inst); Genentech/Roche (Inst); GlaxoSmithKline (Inst); Merck (Inst); Myriad Genetics (Inst); Oncothyreon (Inst); Sanofi (Inst)
 
Scott Kopetz
Stock and Other Ownership Interests - MolecularMatch
Consulting or Advisory Role - Amgen; Array BioPharma; Bayer; Genentech; Merrimack; MolecularMatch; Roche; Sanofi; Taiho Pharmaceutical
Research Funding - Amgen (Inst); Array BioPharma (Inst); Biocartis (Inst); EMD Serono (Inst); Genentech/Roche (Inst); Guardant Health (Inst); MedImmune (Inst); Novartis (Inst); Sanofi (Inst)
 
W. K. Alfred Yung
Honoraria - DNAtrix
Consulting or Advisory Role - DNAtrix
 
John Heymach
Stock and Other Ownership Interests - Bio-Tree; Cardinal Spine
Consulting or Advisory Role - Abbvie; ARIAD; AstraZeneca; AstraZeneca; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Calithera Biosciences; Genentech; Medivation; Novartis; Oncomed; Synta
Research Funding - AstraZeneca (Inst)
 
Siqing Fu
No Relationships to Disclose
 
Kenna Rael Shaw
No Relationships to Disclose
 
Funda Meric-Bernstam
Honoraria - Genentech; Roche
Consulting or Advisory Role - Celgene; Clearlight Diagnostics; Genentech; Inflection Biosciences; Novartis; Pieris Pharmaceuticals; Roche
Research Funding - Aileron Therapeutics; AstraZeneca; Bayer; Calithera Biosciences; Curis; CytomX Therapeutics; Debiopharm Group; Effective Pharmaceuticals; Genentech; Jounce Therapeutics; Novartis; PUMA Biotechnology; Taiho Pharmaceutical; Verastem; Zymeworks